seprase inhibitors (Molecular Insight)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Nameseprase inhibitors (Molecular Insight)

Drug Alias NameFAP-alpha antagonists (Molecular Insight)iodine-131-MIP-1232Fibroblast-activating protein antagonists (Molecular Insight)MIP-1233MIP-1260 +[11]

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentSmall molecules +[4]

Mechanisms of ActionFibroblast activation protein alpha inhibitors

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMolecular Insight Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMolecular Insight Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A